Pete has over 30 years of health care operating and venture capital experience. In addition to co-founding Thomas, McNerney & Partners, Pete co-founded Coral Ventures in 1992, where he was responsible for health care investing. Pete has served on the board of a number of the Coral Ventures' and Thomas, McNerney and Partners' portfolio companies. Prior to joining Coral in 1992, Pete was a co-founder and Managing Partner of The Kensington Group, a firm specializing in providing management services to early stage companies in the health care field. In 1986, he founded and was Chief Executive Officer of Memtec North America, a company established to commercialize cross flow membrane microfiltration technology in North America. Previously, Pete spent 11 years with Baxter Healthcare Corporation, where he held various general management positions in the U.S., Europe, Middle East and Southeast Asia. He has served as President of the Minnesota Venture Capital Association and is on the Board of Trustees of Blue Cross and Blue Shield of Minnesota. A Certified Public Accountant, Pete received a B.A. from Yale and an M.B.A. from Stanford University.  Pete was a 2014 fellow at Harvard's Advanced Leadership Initiative program.

• B.A., Yale University
• MBA, Stanford University

• Founder & Senior Advisor, Thomas, Mcnerney & Partners, 2001-present
• Partner, Coral Ventures, 1992-2001
• Partner, The Kensington Group, 1990-1992
• Chief Executive Officer, Memtec North America, 1986-1989
• Management, Baxter Healthcare, 1975-1986

Field Study (KIEI-498-0)
Field Studies include those opportunities outside of the regular curriculum in which a student is working with an outside company or non-profit organization to address a real-world business challenge for course credit under the oversight of a faculty member.

Complexities of Early Stage Health Care Investing and Entrepreneurship (HCAK-927-0)
The objective of the course is to educate students on the complex challenges of founding, building and investing in innovative early stage health care companies. Many of the challenges are common to all industries but the class will review those that are unique to health care. The regulatory environment, the disjointed system of reimbursement and the rules governing intellectual property often determine success or failure in health care, and the ultimate customer is increasingly influenced by multiple stakeholders, which can often lead to un-economic decisions. To add to the complexity there are different technology or science-based segments within health care each with their own challenges, medical devices, health care services (including IT) and life sciences. We will review the different business models, customers, distribution channels, business challenges, innovation processes, etc. of each of these segments and why they are different. This is not a course that teaches the fundamentals of either health care or early stage investing. Knowledge of one or both will provide the student with a more complete learning experience. The course will be comprised of both classroom and experiential learning. Students will be placed on teams and each team will be paired with an early stage company at MATTER, a large health care incubator based in Chicago. Students will spend time both in Evanston and downtown. The first half of the course will provide an overview of important issues and is more classroom based and during the second half the amount of classroom time will diminish and teams will spend spend time with their MATTER partners and work in the field as required for the project. MATTER (matter.heatlh) is located in downtown Chicago and is home to approximately 200 early stage health care companies. MATTER also provides a focal point for the health care ecosystem in the Chicago area, one that includes larger health care companies as well as venture capitalists, health systems and payers. The objective is to provide each student with a first-hand appreciation of the challenges faced by early stage health care companies and to give an opportunity to the students to add real value to those companies.

NUVention: Medical Innovation II (HCAK-916-0)

**HCAK-915 is a two-quarter sequence course in conjunction with HCAK6**

NUvention Medical is a two term, interdisciplinary course designed to give students the experience of being an innovator and entrepreneur in the world of medical devices and health information technology. Students form teams and each team conceives of or identifies an innovative new product or service that meets an existing market need and develops a prototype and a plan to commercial the product or service. Students from Feinberg School of Medicine, McCormick School of Engineering, Pritzker School of Law and Kellogg School of Management will participate in the course. Each team will have at least one student from each school. In the fall term, student teams will explore unmet market needs, understand market characteristics that are important to investors, conceive of or identify an innovative product with a convincing value proposition and "pitch" their idea. In the winter term, the teams will be expected to analyze the customer and influential stakeholders, formulate a commercialization plan and develop the appropriate regulatory, intellectual property and reimbursement strategies. These will be incorporated into a business plan and an investor presentation. Each team will also be required to develop a viable prototype. Both the fall pitch and final presentation will be made to a group of experienced health care executives and investors some of whom help sponsor the course. Students who are interested in learning how to start a business in the area of medical technology are welcome to apply to the course. Knowledge of he health care industry is certainly helpful but not a requirement. The course puts a premium on individual initiative, an interest in the health care industry and the ability to work effectively on a multi disciplinary team. The course will provide opportunities to observe clinicians (shadowing) and learn from experienced hospital managers. To take advantage of this, students will need to complete the necessary paperwork and gain the proper hospital clearances, a process that takes approximately 30 days. This process can start as soon as the student is accepted to the course and should ideally be completed before the first class

.

Permission from the student's school faculty representative is required to register. Students must take both the fall (I) and winter (II) quarter courses, in sequence, and will earn 2.0 credits after successfully completing both courses. Students in the 2 Year Full Time program and the Evening & Weekend program must have completed one full year. Students in the 1 Year program need to have completed the summer quarter.

NUVention: Medical Innovation I (HCAK-915-0)

**HCAK-915 is a two-quarter sequence course in conjunction with HCAK-916**

NUvention Medical is a two term, interdisciplinary course designed to give students the experience of being an innovator and entrepreneur in the world of medical devices and health information technology. Students form teams and each team conceives of or identifies an innovative new product or service that meets an existing market need and develops a prototype and a plan to commercial the product or service. Students from Feinberg School of Medicine, McCormick School of Engineering, Pritzker School of Law and Kellogg School of Management will participate in the course. Each team will have at least one student from each school. In the fall term, student teams will explore unmet market needs, understand market characteristics that are important to investors, conceive of or identify an innovative product with a convincing value proposition and "pitch" their idea. In the winter term, the teams will be expected to analyze the customer and influential stakeholders, formulate a commercialization plan and develop the appropriate regulatory, intellectual property and reimbursement strategies. These will be incorporated into a business plan and an investor presentation. Each team will also be required to develop a viable prototype. Both the fall pitch and final presentation will be made to a group of experienced health care executives and investors some of whom help sponsor the course. Students who are interested in learning how to start a business in the area of medical technology are welcome to apply to the course. Knowledge of he health care industry is certainly helpful but not a requirement. The course puts a premium on individual initiative, an interest in the health care industry and the ability to work effectively on a multi disciplinary team. The course will provide opportunities to observe clinicians (shadowing) and learn from experienced hospital managers. To take advantage of this, students will need to complete the necessary paperwork and gain the proper hospital clearances, a process that takes approximately 30 days. This process can start as soon as the student is accepted to the course and should ideally be completed before the first class

.

Permission from the student's school faculty representative is required to register. Students must take both the fall (I) and winter (II) quarter courses, in sequence, and will earn 2.0 credits after successfully completing both courses. Students in the 2 Year Full Time program and the Evening & Weekend program must have completed one full year. Students in the 1 Year program need to have completed the summer quarter.

Field Study (FINC-498-0)
Field Studies include those opportunities outside of the regular curriculum in which a student is working with an outside company or non-profit organization to address a real-world business challenge for course credit under the oversight of a faculty member.